This is an I-Heart podcast.

Guaranteed Human.

Welcome to Wellness on Mass.

I'm Dr. Nicole Sapphire.

This is your weekly rundown.

Well, it's very timely what we're going to start out with this week because there have been a

couple of significant developments happening all at once week because there have been a couple of significant

developments happening all at once and they're getting a lot of attention. So first,

we talked about peptides earlier this week, right? Well, as if he listened to our podcast

himself, as though wellness en masse was something that Secretary Kennedy, RFK Jr., listened to,

RFK Jr. is now signaling a push for the FDA to reevaluate peptides. Now, peptides, as we

mentioned this week, have been a gray zone topic for a while. They're used in wellness, anti-aging,

and even performance setting like athletes,

but not always clearly regulated

or consistently studied at the level we would hope for

for widespread medical use.

Now, if the FDA does move forward,

as Secretary Kennedy is signaling they might, they would reevaluate some of these peptides.

This could mean tighter oversight, more structured clinical data requirements, and potentially clear guidance for both doctors like myself and the patients.

That's not a bad thing. Let me tell you, it's really not.

Do I love the idea of regulation? No, but when it comes to medical things, regulation is there

to protect us, right? It really is. It could maybe limit access in the short term, especially for people who are currently using

...